Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Accumulated Expenses (2016 - 2017)

Wave Life Sciences' Other Accumulated Expenses history spans 3 years, with the latest figure at $156000.0 for Q4 2017.

  • For Q4 2017, Other Accumulated Expenses fell 83.54% year-over-year to $156000.0; the TTM value through Dec 2017 reached $156000.0, down 83.54%, while the annual FY2017 figure was $156000.0, 83.54% down from the prior year.
  • Other Accumulated Expenses reached $156000.0 in Q4 2017 per WVE's latest filing, down from $948000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $948000.0 in Q4 2016 to a low of $156000.0 in Q4 2017.
  • Average Other Accumulated Expenses over 3 years is $465750.0, with a median of $379500.0 recorded in 2015.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 168.56% in 2016, then tumbled 83.54% in 2017.
  • A 3-year view of Other Accumulated Expenses shows it stood at $353000.0 in 2015, then surged by 168.56% to $948000.0 in 2016, then crashed by 83.54% to $156000.0 in 2017.
  • Per Business Quant, the three most recent readings for WVE's Other Accumulated Expenses are $156000.0 (Q4 2017), $948000.0 (Q4 2016), and $353000.0 (Q4 2015).